Efficacy, cycle control, and safety of two triphasic oral contraceptives: CyclessaTM (desogestrel/ethinyl estradiol) and Ortho-Novum® 7/7/7 (norethindrone/ethinyl estradiol) a randomized clinical trial
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 61 (5) , 295-302
- https://doi.org/10.1016/s0010-7824(00)00108-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparationsContraception, 1999
- Clinical comparison of triphasic norgestimate/35 μg ethinyl estradiol and monophasic norethindrone acetate/20 μg ethinyl estradiol: Cycle control, lipid effects, and user satisfactionContraception, 1999
- Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestinContraception, 1997
- Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular diseaseContraception, 1995
- Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrelContraception, 1995
- Androgenic effects of oral contraceptives: Implications for patient complianceThe American Journal of Medicine, 1995
- New progestogens in oral contraceptionContraception, 1994
- Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiolBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- The patient's reaction to side effects of oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1989
- Phasic approach to oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1987